Despite its important role in pathogenesis, there is no evidence of the effectiveness of anti-TNF-α antibodies in MM treatment; however, both IL-6 and TNF-α are correlated with disease activity in MM [17,18,19]. Here, IL6 is linked to Miyoshi myopathy.